Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Ana Baptista P, Magalhães S (2015) Screening for Fabry Disease in Left ventricular hypertrophy: documentation of a Novel mutation. Arq Bras Cardiol 105:139–144
2. Coelho T, Maurer MS, Suhr OB (2013) THAOS-The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 29:63–76
3. Baptista A, Magalhães P, Leão S et al (2015) Screening for fabry disease in left ventricular hypertrophy: documentation of a novel mutation. Arq Bras Cardiol 105:139–144
4. Yogasundaram H, Kim D, Oudit O et al (2017) Clinical features, diagnosis,and management of patients with Anderson-Fabry Cardiomyopathy. Can J Cardiol 33:883–897
5. Putko BN, Wen K, Thompson RB et al (2015) Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment. Heart Fail Rev 20:179–191
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献